Q11224 (Q11224): Difference between revisions
Jump to navigation
Jump to search
(Removed claims) |
(Changed an Item) |
||||||||||||||
Property / EU contribution | |||||||||||||||
24,083,996.56 Czech koruna
| |||||||||||||||
Property / EU contribution: 24,083,996.56 Czech koruna / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / EU contribution | |||||||||||||||
963,359.8624 Euro
| |||||||||||||||
Property / EU contribution: 963,359.8624 Euro / rank | |||||||||||||||
Preferred rank | |||||||||||||||
Property / EU contribution: 963,359.8624 Euro / qualifier | |||||||||||||||
exchange rate to Euro: 0.04 Euro
| |||||||||||||||
Property / EU contribution: 963,359.8624 Euro / qualifier | |||||||||||||||
point in time: 10 January 2020
| |||||||||||||||
Property / budget | |||||||||||||||
43,285,400.0 Czech koruna
| |||||||||||||||
Property / budget: 43,285,400.0 Czech koruna / rank | |||||||||||||||
Normal rank | |||||||||||||||
Property / budget | |||||||||||||||
1,731,416.0 Euro
| |||||||||||||||
Property / budget: 1,731,416.0 Euro / rank | |||||||||||||||
Preferred rank | |||||||||||||||
Property / budget: 1,731,416.0 Euro / qualifier | |||||||||||||||
exchange rate to Euro: 0.04 Euro
| |||||||||||||||
Property / budget: 1,731,416.0 Euro / qualifier | |||||||||||||||
point in time: 10 January 2020
|
Revision as of 00:21, 12 February 2020
Project in Czech Republic financed by DG Regio
Language | Label | Description | Also known as |
---|---|---|---|
English | No label defined |
Project in Czech Republic financed by DG Regio |
Statements
24,083,996.56 Czech koruna
0 references
43,285,400.0 Czech koruna
0 references
55.64 percent
0 references
16 April 2018
0 references
30 April 2020
0 references
AUMED, a.s.
0 references
14300
0 references
Předložený projekt řeší problematiku přípravy nové lékové formy specifických imunomodulátorů na bázi transfer faktorů (TF) a metod testování jejich imunobiologického potenciálu a. (Czech)
0 references
Identifiers
CZ.01.1.02/0.0/0.0/16_083/0010301
0 references